Business
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call
Notice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call Notice ...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nNotice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nNotice of Cipher Pharmaceuticals Inc. Q4 and Year-End 2015 Conference Call\nCanada NewsWire\nMISSISSAUGA, ON, Feb. 9, 2016\n\n\n\nMISSISSAUGA, ON, Feb. 9, 2016 /CNW/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) (\"Cipher\" or \"the Company\") today announced it will host a conference call for its Q4 and full-year 2015 financial results on Wednesday, February 24, 2016.\n\nQ4 AND YEAR-END 2015 CONFERENCE CALL\n\nWHEN: Wednesday, February 24, 2016 at 8:30AM ET\n\nCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through www.cipherpharma.com or http://bit.ly/1Q54Na7.  An archived replay of the webcast will be available for 90 days.\n\nAbout Cipher Pharmaceuticals Inc.Cipher Pharmaceuticals (NASDAQ:CPHR; TSX:CPH) is a rapidly growing specialty pharmaceutical dermatology company with a diversified portfolio of commercial-stage products with the goal of becoming the most customer-centric dermatology company in North America. \n\nCipher completed seven transactions in 2015, including the acquisition of Innocutis and its nine branded dermatology products, to build its U.S. commercial presence, expand its Canadian dermatology franchise and broaden its pipeline. Cipher is well-capitalized to drive long-term, sustained earnings growth by leveraging its proven clinical development capabilities and efficient commercial execution. For more information, visit www.cipherpharma.com.\n\n\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\n\n\n\nInvestors: In Canada: Craig Armitage, LodeRock Advisors, (416) 347-8954, [email protected]; In the United States: Thomas Hoffmann, The Trout Group LLC, (646) 378-2931, [email protected] CNW Group 2016","length":3157,"tagName":"div"}]